
|Videos|October 20, 2015
Dr. Minesh Mehta Talks About A Newly-Approved Device To Treat Glioblastoma
Minesh Mehta, MBChB, talks about the recently FDA-approved Optune used to treat newly diagnosed glioblastoma. The device utilizes alternating electric fields to inhibit tumor cell growth.
Advertisement
Minesh Mehta, MBChB, medical director, Maryland Proton Treatment Center, talks about Optune, the recently FDA-approved device used to treat newly diagnosed glioblastoma. The system utilizes alternating electric fields to inhibit tumor cell growth.
Mehta says that he hopes the device will become more widespread in the future after more research comes out about its clinical benefit.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
4
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
5








































